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Introduction   
In 1852, George Stokes introduced the word fluorescence to describe the phenomenon of 
‘internal reflection’ – an emission of blue light - that he had observed when examining sunlit 
samples of the mineral fluorspar, and that Herschel, Brewster and Becquerel had described 
earlier when irradiating solutions of quinine salts. 1 The calcium fluorite samples Stokes 
examined were doped with Eu(II), and led to a blue emission; with an Yb(II) dopant, yellow-
green light is emitted. 2 These beautiful mineral samples are still being mined in upper 
Weardale, County Durham in the North-East of England, and create a local link to the series 
of very bright, red-emitting Eu(III) complexes that are described herein. 
Europium emission occurs on a millisecond timescale over the range 580 to 720 nm, and has 
been used for many years in a wide range of applications in the materials and biosciences, 3-7 
from security printing in bank notes to reporters for time resolved bioassays. As the 
transitions between f electronic energy levels are symmetry forbidden, direct excitation of the 
Eu ion is very inefficient, and the 5D0 Eu excited state is preferably populated via a 
sensitisation mechanism. This process involves light absorption by a proximate chromophore, 
followed by intramolecular energy transfer to the Eu ion. In order that the Eu ion emits light 
with a high overall quantum yield in water, it needs to be efficiently shielded from the 
external environment, to minimize non-radiative deactivation processes, such as electron 
transfer or vibrational energy transfer to overtones of XH oscillators (X = O, N and C). 8 
Thus, the ligand used to complex the Eu ion must be octa- or nonadentate to exclude 
coordinated water molecules and should encapsulate the metal ion effectively. The brightness, 
B, of the complex is the key parameter to maximize in this context. It is the product of the 
molar extinction coefficient, ε, at λexc and the overall quantum yield for Eu emission, φem ,  in 
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the background medium used.  For excitation at 337 or 355 nm in aqueous solutions, typical 
values of B for Eu complexes lie in the range 1 to 3 mM-1cm-1 3,5,9,10 compared to the value of 
9 mM-1cm-1 reported for the terbium cryptate, Tb-LumiphorTM, that is used as a donor in a 
variety of FRET assays. 11  
The long-lived nature of Eu emission allows its selective detection in time-resolved 
measurements, avoiding the experimental complications that may occur from light scattering 
or interference from endogenous fluorescence. For applications in optical imaging using 
luminescence microscopy, probe brightness needs to be assessed with due consideration to 
the time-resolved measurement and the local concentration of the probe, by using the 
following expanded relationship for probe brightness, B', eq. 1: 12 
 
     B' (λ,c) = ηε φ ∫ e-kt.dt    (1) 
 
When applied to cellular imaging, c is the complex loading concentration, λ is the 
excitation wavelength, k is the radiative rate constant for emission and η is an 
accumulation parameter, reflecting the amount of complex internalised.  The integral has 
limits (tacq + td) and td ; tacq is the spectroscopic integration time or microscopy acquisition 
time and td is the delay time following pulsed excitation.  
 
Design criteria for very bright europium complexes 
Given that Eu(III) most commonly adopts a coordination number of nine, nonadentate ligands 
have been often considered and can be based on various C3 symmetric core structures, such as 
acyclic triamines or triaza-macrocycles, such as triazacyclononane (9-N3).  The 9-N3 
macrocyclic ring is  
 
    
 
Scheme 1       The essential design elements and structural features in emissive Eu probe design. 
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conformationally rigid and its chelate bite is matched to the requirements of small octahedral 
ions (e.g Fe(III), Ga(III), Ni(II), Co(III)) 13,14 as well as larger lanthanide ions capable of 
adopting a tri-capped trigonal prismatic coordination geometry.15 The primary binding free 
energy term in Eu(III) coordination complexes is Coulombic. The tripositive ion therefore 
requires a trianionic ligand to enhance complex stability, and carboxylates, phosphinates and 
phenolates can be considered as preferred donors.  The latter two series afford a greater steric 
demand around the Eu ion, and variation of the substituent at P or on the phenolate ring gives 
control to the extent of shielding of the excited Eu ion,  (Scheme 1), inhibiting collisional 
deactivation processes.  The spectral form of Eu emission is a sensitive function of local 
complex symmetry and donor atom polarisability (vide infra). 3,16-18   The imposition of local 
C3 symmetry coupled with the introduction of more polarisable ligand donors (e.g. py-N > 
amine-N > O; carboxylate O > phosphinate O) leads to enhanced emission intensity of the 
electric-dipole allowed transitions around 610-620 nm (5D0 to 7F2) and to lower relative 
intensity in the other emission bands.  
  
 
 
 
 
 
 
 
 
 
 
 
Scheme 2   Jablonski diagram illustrating sensitised emission of Eu(III), either via an intermediate         
     chromophore triplet or a solvent-relaxed internal charge transfer excited state.  
 
In sensitized emission, the structure of the chromophore requires careful consideration in 
order to define the excitation wavelength, maximize absorbance at this wavelength and 
facilitate intramolecular energy transfer to populate the Eu(III) excited state. Given that 
common lasers operate at 337 and 355 nm, powerful laser-driven white light sources operate 
to 380 nm and cheap LEDs function at 385 and 365 nm, these are the preferred target 
wavelengths. Until recently, most chromophores were designed based on the premise that the 
mechanism of Eu excitation involved a triplet excited state, with an energy of >19,000 cm-1  
(Eu 5D0 and 5D1 excited states lie at 17,200 and 19,000 cm-1, Scheme 2), a small singlet-triplet 
energy gap to favour intersystem crossing and a relatively high chromophore oxidation 
potential, to minimize charge transfer quenching of the singlet excited state by the proximate 
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Eu(III) ion. 3,9,19 Following the definition of pyridyl-alkynyl-aryl chromophores (Scheme 1) 
with an intense internal charge transfer (ICT) transition, tunable by substitution of the 
aromatic groups, an expanded series of chromophores has emerged, each with an extinction 
coefficient of about 20 mM-1cm-1 20,21 (Scheme 2).  Energy transfer to a Eu ion, coordinated 
by one or more of the pyridyl N atoms is very efficient, and the 9-N3-based tris-pyridyl-
alkynyl-aryl Eu complexes possess a brightness of around 15 to 30 mM-1 cm-1 in water or 
methanol following excitation in the range 337 to 360 nm. Such a value for the probe 
brightness is higher than that of red fluorescent protein (17 mM-1cm-1). 7,21,22    
The ease of ligand synthesis and of structural permutation is an important final aspect in 
probe design, (Scheme 1).  For example, the ability to tune complex hydrophilicity and to 
enable linkage to targeting groups or to permit bio-conjugation are essential requirements in 
devising a family of complexes.  The more obvious linkage points to the core structure, 
described above, are on the 9-N3 ring carbon, thereby introducing a stereogenic centre, or on 
the peripheral aryl groups, such as via the alkoxy substituents. In the latter case, 
desymmetrisation of the complex requires that one of the alkynyl moieties be distinguished 
from the other two. In this regard, the intermediacy of mono-BOC-9-N3 permits selective 
dialkylation and allows differentiation of the third chromophore group. 23  
 
Structural Analysis of Europium Complexes in C3 Symmetry    
 The structures of the parent Eu complexes,  [Eu.L1-3], have been determined by X-ray crystallography, 
(Figure 1); in each case an isostructural series was defined across the whole 4f block series. 24-27     
        
   Figure 1     Views from below, into the 9-N3 ring for the C3 symmetric X-ray structures of  
Upper left: Λ-[Eu.L1]; upper right: Λ-[Eu.L2] (i.e the R−Λ−δδδ isomer); lower S-∆-(λλλ)-[EuL3]3+ (left) 
and R-Λ-(δδδ)-[EuL3]3+ (right) (120 K) (CCDC numbers: 206375-8; 836097-102; 965909-11) 24-27 
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In these structures, the europium ion adopts a tricapped trigonal prismatic geometry, and the 
complex exists as a ∆/Λ racemate in solution. Resolution of the triphosphinate and 
tricarboxylate complexes by chiral HPLC has been achieved 28, and the half-lives for 
racemisation at 333K in water were 185(±20) and 245(±35) hours respectively, compared to 5 
milliseconds for the tris-chelate complex [Eu(DPA)3]3- measured under the same conditions, 
where dissociative ligand exchange provides a much faster pathway for racemisation.   
The introduction of an S chiral substituent on the amide moiety in [Eu.L3]3+ induced 
preferential formation of the ∆ complex, with an isomer ratio of 7:1 (∆/Λ) being observed in 
solution by 1H NMR. Complete stereocontrol, leading to preferential formation of one 
enantiomer,  was observed following introduction of a chiral centre directly onto the 9-N3 
ring. Thus, a C-alkyl (alkyl = Me, iPr or benzyl) 9-N3 platform derived from an R amino-acid 
precursor29 led to formation of the ∆ complex only, confirmed by NMR and HPLC analyses.28    
 
           
Figure 2       upper: Crystal structure of SSS-∆−(λλλ) [Eu.L4] (CCDC 948247)28 ; lower: (a) the 
pseudo-equatorial positions of the pro-R hydrogens on the ring; (b) the corner position of the pro-R 
hydrogen (filled arrow where a C-substituent will prefer to reside), vs the side position of the pro-R 
hydrogen (dashed arrow); (c) the ring torsional angles - ‘corner’ carbons are marked with *  (i.e. those 
sites between two gauche bonds, thereby defining the rigid quadrangular [333] ring conformation).  
The very high stereoselectivity (>97%) observed in complex formation for the ring C-
substituted series of triazacyclononane complexes was rationalised by considering the X-ray 
structure of the para-bromo derivative, [Eu.L4]. The enantiomer shown (Fig. 2) has an S 
configuration at phosphorus and the complex helicity is Δ (or P).  The ∆ configuration was 
shown by CPL and CD studies to be formed in complexes with an R-stereogenic centre at the 
ring carbon.  In this case, the pro-R hydrogen atom, which is the site where the ring 
substituent would reside, is in one of two pseudo-equatorial positions (Fig. 2a). To minimize 
steric repulsion, the most likely site occupied by the C-substituent is that directed away from 
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the three pyridyl arms (Fig. 2b), consistent with substitution of a corner (rather than a side) 
carbon atom (Fig. 2c).  
The structure of the p-methoxyphenyl-alkynyl-pyridyl complex, [Eu.L5] has been reported. 23,     
In this case the complex was slightly distorted from C3 symmetry, and the phosphorus phenyl  
substituents were directed away from the plane of the 9-N3 ring to create a significant steric 
barrier (Figure 3). In agreement with this observation, the emission lifetime of the Eu(III) ion 
in [Eu.L5] was 30% longer compared to the carboxylate analogue in water, 21 consistent with 
reduced local quenching by closely diffusing waters and an increased complex rigidity.   
     
Figure 3  Experimental X-ray (bold) and DFT calculated (ghost: Y analogue) structures for the 
p-methoxyphenyl-alkyne derivative, [Eu.L5], highlighting the steric bulk afforded by the three P-
phenyl substituents that shield the upper face of the complex (CCDC 857545). 21,23    
Synthesis of the chromophores and complexes 
A simple retrosynthetic analysis of the target Eu complexes, such as [Eu.L5], reveals that the 
key reactions involve creation of a C-C bond between a 4-substituted pyridine and an aryl 
substituted  alkyne, and a C-N bond-forming reaction between the ring N and a suitable 
alpha-substituted pyridylmethyl electrophile. A representative synthesis of a 2,4,6- 
trisubstituted pyridine (Scheme 3) highlights the early introduction of the C-P bond, via 
palladium catalysed insertion into a P-H bond, followed by intramolecular CH activation of 
the ring methyl group, via a Boekelheide rearrangement of the pyridine N-oxide. A 
Sonogashira coupling reaction generates the conjugated alkyne, and subsequent mesylation of 
the unmasked alcohol provides the required electrophile to alkylate the 9-N3 ring. 12,21,23 
 
  
  
 
 
 
  
 
 
Scheme 3 Synthesis of a typical 2,4,6-trisubstituted pyridine intermediate. 12,21,23  
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 Scheme 4     Synthesis of the tris-glucamide derivative, [Eu.L6]. 12,30    
 
The linear forward synthesis of a complex functionalized at the phenylalkoxy position (Scheme 4) is 
typical of more than a dozen examples in which the Eu(III) ion is introduced in the final step, and the 
neutral complex is readily purified by reverse phase HPLC. An alternative, more divergent, strategy 
has been implemented wherein the 4-bromopyridyl europium complex, [Eu.L4] is used as a common 
intermediate (Scheme 5). This strategy allows the synthesis of a wide range of complexes with 
different aryl-alkynyl moieties, using the Sonogashira reaction in a product-forming step. 31 
 
 
 
   
 
 
 
Scheme 5 Retrosynthetic analysis and an example of the synthesis of an S-lysine derived  
  enantiopure complex, Λ-[Eu.L7]. 31 
 
Photophysical properties of europium complexes  
The emission spectral form of the parent complexes, [Eu.L1-3], strongly resembles that of 
[Eu(DPA)3]3-, with a ratio of intensities of the ΔJ = 2/ΔJ = 1 bands (around 616 and 590 nm: 
Scheme 2) of between 4 and 5 to one in each case. In contrast, for the C3-symmetric 
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complexes [Eu(ODA)3]3- and [Eu(IDA)3]3- (ODA = oxydiacetate; IDA = iminodiacetate; DPA 
= 2,6-pyridine-dicarboxylate),32 in which the same number of transitions is observed, the ΔJ = 
2/ΔJ = 1 intensity ratio is near unity for [Eu(ODA)3]3- and 2.5:1 for [Eu(IDA)3]3-, (Figure 4).  
With the extended alkynyl-aryl complexes, the nature of the P substituent (Me vs Ph) does not 
change the spectral form significantly (Fig. 4 C vs D), although one of the ∆J = 2 transitions 
around 620 nm is much stronger than in [Eu(DPA)3]3-.   
  
Figure 4.  Comparison of total emission spectra for C3-symmetric Eu(III) complexes: A) [Eu(IDA)3]3- 
(λexc = 395 nm, H2O, pH 8.5); B) [Eu(DPA)3]3- (λexc = 395 nm H2O, pH 8.5); C) [Eu.L9b]3- (λexc = 322 
nm, H2O, pH 7.4); D) [Eu.L6] (λexc = 332 nm, H2O, pH 7.4)12,23,32  
In europium emission spectra, the oscillator strength of the ΔJ = 1 transitions (around 590 
nm) is magnetic-dipole (MD) allowed and independent of the ligand environment. In contrast, 
the ΔJ = 2 transitions (around 615 nm) are electric-dipole (ED)-allowed and hypersensitive to 
ligand perturbation. This behaviour can be rationalised in terms of a ligand polarization 
model16 wherein electric-quadrupole-allowed transitions (e.g. 5D0 to 7F2) gain significant ED 
strength via a quadrupole (Ln3+)-induced dipole (ligand donor) coupling mechanism.  Induced 
dipoles on the ligands are created by direct coupling to the ED components of the radiation 
field. Thus, 4f−4f ED strength can be related to ligand dipolar polarisabilities and to the 
anisotropies of these polarisabilities.17 Among the ligand donors considered, the polarizable 
pyridyl groups are common and predominantly define the ΔJ = 2 transition oscillator strength. 
Comparing [Eu.L1] and [Eu.L3], very similar spectra were observed but the ΔJ = 2/ΔJ = 1 
intensity ratio was 20% higher, consistent with the greater polarisability of the carboxylate 
over the phosphinate oxygens.  
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Figure 5  Europium complexes of varying charge and hydrophilicity (Table 1). 12,21,27,33  
 
The extinction coefficients of the Eu complexes with extended alkynyl groups lies in the 
range 55 to 60 mM-1cm-1 in water, with lifetimes of around 1 ms and emission quantum yields 
of 22 to 37%, giving brightness parameters, B, of 12 to 22 mM-1cm-1, (Table 1).  These are the 
highest values reported for emissive lanthanide complexes in solution.  
 
Table 1 Selected photophysical and hydrophilicity data for the europium complexes 
[EuL6] and [EuL8-13] (H2O, 295 K) 12,27,33 
 
 
Complex 
 
 
τ /ms 
 
ε /mM-1 cm-1 
 
φem /% 
 
log Pa 
 
[Eu.L6] 
 
1.07 
 
56.5 
 
26 
 
n.d. 
 
[Eu.L8] 
 
1.03 
 
58.1 
 
22 
 
+1.4 
 
[Eu.L9a]3- 
 
1.05 
 
56.6 
 
26 
 
-2.2 
 
[Eu.L10]3- 
 
1.06 
 
56.8 
 
27 
 
-1.5 
 
[Eu.L11]3+ 
 
0.80 
 
56.5 
 
37 
 
+0.3 
 
[Eu.L12]3- 
 
1.04 
 
60.1 
 
29 
 
-1.2 
 
[Eu.L13]3- 
 
1.11 
 
58.0 
 
31 
 
+0.7 
 
a log P data refer to the distribution of the complex between water and octan-1-ol 
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Earlier work with tris-dipicolinate complexes possessing arylalkynyl substituents, showed 
that europium sensitisation involved an intramolecular energy transfer process involving a 
relaxed and broad ICT excited state, particularly for strongly conjugated electron-donating 
groups in the aryl group.20b In the case of weaker electron releasing groups, the ICT state lies 
at higher energy and consequently a contribution from the classical triplet mediated 
sensitisation process remains possible.20a Variable temperature phosphorescence 
measurements on the analogous Gd complexes clearly indicated the presence of a triplet 
excited state at approximately the same energy as the ICT state, (Scheme 2, above). Thus, two 
sensitisation pathways, namely the triplet state mediated or the direct ICT process could be 
simultaneously involved in europium sensitisation. 21 Whatever the mechanism, the Eu 
complexes show excellent stability with respect to photobleaching, following laser excitation 
at 355 nm.12 Such behaviour contrasts with the instability of many organic dyes or of metal 
complexes bearing sensitisers which have an excited state with nπ* character. 8 
These chiral Eu complexes are excellent candidates for study using circularly polarized 
luminescence (CPL) spectroscopy. 25-28,31,34,35   The use of CPL spectroscopy allows spectral 
resolution (Figure 6) of the observed transitions, notably in the ∆J = 2 and 4 manifolds, for 
the two examples shown here using [Eu.L2] and [Eu.L7]. The very high brightness of [Eu.L7] 
(B = 33 mM-1cm-1 in MeOH, 295K) allowed spectral acquisition in a few minutes using a 3 
micromolar solution of the complex. 31 Such enhanced sensitivity with this new range of 
probes augurs well for the implementation of CPL microscopy, to track the fate of the 
enantiopure Eu probes and signal any changes in their chiral environment. Proof of pricnciple 
studies have already demonstrated changes in complex helicity as a result of selective binding 
to an abundant endogenous chiral anion (e.g. lactate) or a well-defined site in a common 
protein, e.g. albumin or α1-AGP. 34-38  
  
Figure 6  Circularly polarized luminescence spectra for: left, ∆-[Eu.L2] (blue) and the Λ isomer 
(red) (50µM, H2O, 295K, λexc 280 nm); right, ∆ (blue) and Λ (red) [Eu.L7] (3 µM; 295K, MeOH, λexc 
360 nm), showing the enhanced spectral resolution, e.g. for the ∆J = 4 transitions around 700 nm (viz. 
Fig. 4 [C and D] above). 25,26,31  
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Cellular optical imaging 
The neutral and cationic Eu complexes (Figure 7) are taken into mammalian cells quite 
efficiently by macropinocytosis 12,23, a process that is promoted by addition of phorbol esters 
and inhibited by amiloride and wortmannin.39 Macropinocytosis is a form of endocytosis that 
leads to the formation of leaky macropinosomes of irregular size and shape, the contents of 
which are readily released into the cytoplasm. This pathway is an attractive means for 
delivery of the luminescent complexes into the cell, as the complexes can readily escape from 
the macropinosome, allowing vesicular trafficking to other compartments.  
The complexes are well tolerated by a wide variety of primary and transformed cell lines, 
with IC50 values generally greater than 100 µM. Cell uptake can be quantified by measuring 
the internalised Eu by ICP-mass spectrometry, and the high brightness means that the 
concentration of the complex in the incubation medium usually needs to be in the range 500 
nM to 20 µM. Uptake in plant cells, roots and pollen tubes has also been examined, with 
[Eu.L15]- acting as a convenient probe to label the cell walls of plant or root hairs. 40     
 
 
 
Figure 7  Examples of functionalized Eu complexes, including selected conjugates 12 
 
The intracellular localization profile of the complexes shown above (Fig. 7) has been studied, and 
examples of complexes selectively staining the mitochondria (e.g. [Eu.L6], late endosomes and 
lysosomes (e.g. [Eu.L9a]3-) and the endoplasmic reticulum (e.g. [Eu.L16]6+) were identified.  A 
consequence of the high brightness of the probes is that there is sufficient signal to permit rapid 
acquisition of both the Eu spectral image and the lifetime of the complex internalized inside the cell. 
Such studies using time-resolved CCD detection allow the speciation of the Eu complex to be 
identified; in the majority of cases these reveal the same spectral fingerprint and lifetime to that 
measured in vitro. Such experiments confirm the integrity of the probe when localised inside the cell, 
(Figure 8) and an absence of change in lifetime confirms resistance to excited state quenching by 
endogenous electron rich species, such as protein Tyr residues, urate, ascorbate or other reducing 
agents. 41  
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.  
 
     
Figure 8       left: view of the mitochondrial network of an NIH-3T3 cell stained with the tris-glucamide 
complex, [Eu.L6]; right: confocal microscopy images showing: (a) the DAPI stained nucleus (λexc 355 
nm, λεm 400−450 nm); (b) MitoTracker Green staining of the mitochondrial network (λεxc 488 nm, λem 
500−530 nm); (c) mitochondrial localisation of [Eu.L7] in NIH 3T3 cells (4h, 30 μM, λexc 355 nm, λem 
605–720 nm); (d) a merged image showing co-localisation (P = 0.89), (e) spectral profiling of [Eu.L6] 
(24h, 30 μM), (f) the intracellular lifetime for [Eu.L6] (τEu = 1 ms; 24h, 30 μM). 12 
[ROBERT: CAN YOU MAKE THIS AS GOOD A QUALITY AS POSSIBLE…PLEASE..] 
 
 Consideration of Abbé’s law, (d = λ/2(n sinθ), where nsinθ is the numerical aperture (NA) = 
1.4 here, λ is the excitation wavelength and d is the theoretical resolution) reveals that the use 
of 488 nm vs 355 nm excitation improves the intrinsic resolution of confocal microscopy 
from 174 to 126 nm. The images obtained in Figure 8 accord with that view, and the use of a 
phase modulated resolution enhancement technique allowed microscopic resolution of 65 nm 
to be achieved. 12 As a result of the high intrinsic brightness of these Eu probes, the power 
used in pulsed excitation was only 4 mW (<80 nJ/voxel/acquisition). These conditions are 
very different from those used in the past to examine and quantify UV damage to cells, where 
continuous light exposure persists for several seconds or minutes and the impact is a steep 
function of the excitation wavelength.  Much less damage occurs above 340 nm.42 Indeed, in 
control experiments examining healthy mouse skin fibroblasts (NIH-3T3 cells) loaded with 
[Eu.L6] (400 nM), following sequential scanning excitation at 355 nm (6 mW) with a 63x 
objective (NA = 1.4), scanning the same area every 30 minutes for three hours, more than 
90% of healthy cells were observed in the field of view. With pulsed excitation at 365 nm (as 
in Figure 8), even shorter UV exposure times occur. 12  
Examples of responsive probes have also been defined, based on these very bright complexes, 
in which the Eu spectral fingerprint and lifetime is a sensitive and selective function of local 
pH or ionic composition. 30,35,43,44 For example, the reversible intramolecular ligation of the 
sulphonamide nitrogen in [Eu.L21]  is a function of pH. This complex localizes well to the 
endoplasmic reticulum, an organelle that is in equilibrium with the cytosol, so the pH is 
Dalton Trans Perspective 2014 
 13 
equivalent. Careful calibration studies allowed the ratio of two Eu emission bands or the 
modulation of the emission lifetime to signal pH variation (Figure 9).44  Related examples can 
be imagined, based on reversible anion binding to the Eu centre, 43 provided that the probe is 
able to target the organelle of interest selectively. 
 
 
 
 
 
 
 
 
 
Figure 9    pH variation of the Eu emission intensity ratio (∆J = 2/(∆J = 0 +∆J = 1) and excited 
state lifetime (τ) for [Eu.L21] (pKa = 7.15 ±0.05), when the probe is localized in the endoplasmic 
reticulum of mouse skin fibroblasts (NIH-3T3 cells). 44 
 
  
Bioassays based on FRET   
The uptake of Eu complexes into cells by macropinocytosis is a disadvantage if you want to 
develop assays for membrane bound proteins, such as the ubiquitous G-protein coupled 
receptors. 45   A non-specific signal is generated due either to the probe sticking at or entering 
the cell membrane or via binding to immature proteins within the cytosol. 4a Bio-conjugates 
of very water-soluble europium complexes are needed that cannot enter or adhere to cells, at 
concentrations of less than 1 µM.  The cell membrane consists primarily of negatively 
charged phospholipids, so that several series of 9-N3 based complexes have been devised that 
are highly water soluble and negatively charged at physiological pH (Figure 5 above). 33 Any 
interaction with the cell membrane is suppressed by repulsive electrostatic interactions. 
Furthermore, the hydrophilic nature of the integral sulphonate and carboxylate groups masks 
the inherent hydrophobic nature of the three aryl-alkynyl groups, as these are the likely 
entities that engage in non-specific protein or membrane binding.  
In one example, three europium complexes, [Eu.L22-24] (Figure 10) have been compared, one 
of which, [Eu.L22] served as a negative control, as it did not possess peripheral anionic 
substituents. The complexes were evaluated using ‘SNAP-tag’ technology on the G-protein 
coupled receptor, cholecystokinin-2 (CCK-2).46 The labeling of the three benzylguanine-
derivatives on living human embryonic kidney cells (HEK293) or HEK293 cells expressing 
the ‘SNAP-tagged’ CCK-2 (CCK2-ST) receptor was measured, by monitoring the Eu 
luminescence at 620 nm. Significant labelling of the unmodified HEK cells occurred with 
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[Eu.L22], whereas in the other two cases, non-specific labeling was negligible. Such behaviour 
paved the way for TR-FRET ligand binding assays using a fluorescent agonist (λem 665 nm) 
of the CCK receptor, that serves as an acceptor for the long-lived emission from the Eu donor, 
both on a plate reader and using TR-FRET microscopy. 33   
 
 
 
Figure 10          Retrosynthetic strategy to Eu complexes for a ‘SNAP-tagged’ receptor binding assay.33  
[Jurriaan to add a Figure here, as appropriate….colour… and add further 
comments…please…) 
 
Conclusions and Outlook 
The EuroTracker series of emissive complexes based on triazacyclononane possess a 
brightness that is almost an order of magnitude greater than previously reported Eu(III) 
systems, and also larger than that of the recombinant red fluorescent protein. The ease of 
structural manipulation allows close control over the absorption wavelength over the range 
from 330 to 360 nm and permits various points of attachment to targeting vectors or for 
biomolecule labeling. The disubstituted series of complexes possess one coordinated water 
but retain a high quantum yield, and bind anions reversibly.  Appropriate substitution of the 
third ring N should enable the future development of new examples whose emission spectral 
profile and lifetime can be rendered sensitive to pH, pM and pX, with the required selectivity 
for the analyte chosen. Enantiopure complexes can be obtained by C-substitution into the 9-
membered core ring, aiding the development of chiral probes and tags for the exploration of 
CPL spectroscopy and microscopy studies.  
The series of amphipathic complexes are efficiently taken into many mammalian cells by 
macropinocytosis, are non-toxic and localise selectively in certain organelles, allowing them 
to function as selective stains for live-cell imaging studies. By introducing peripheral anionic 
groups on the rod-like chromophore moieties, non-specific cell uptake is inhibited so that 
Dalton Trans Perspective 2014 
 15 
various conjugates can be devised to aid the development of new organelle-targeted cellular 
stains and probes or allow new series of bioassays to be undertaken. 
  
Evidently, the future is bright for such rare earth complexes; Sir George Stokes would most 
probably have approved.   
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